Search Results 71-80 of 21346 for anti-TNF drugs

  1. Tocilizumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    This medicine helps keep joint damage from getting worse after other medicines (eg, adalimumab, etanercept, infliximab) have been used and did not work well. It ...

  2. Drugs - Drug and supplement information - MayoClinic.org

    Look up information about prescription drugs, over-the-counter medications, herbs, vitamins and supplements.

  3. Adalimumab-Ryvk (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

    Safety of anti-TNF agents in pregnancy. J Allergy Clin Immunol. 2021 Sep; 148 (3):661-667. View PubMed; Katz S, Kane SV. Myths and Misconceptions in the ...

  5. Anti-seizure medications: Relief from nerve pain - Mayo Clinic

    Anti-seizure drugs designed to treat epilepsy often are used to control nerve pain associated with diabetes, shingles, and other types of nerve damage.

  6. A Study to Evaluate Response to Adalimumab in Rheumatoid Arthritis Patients - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... A Study to Evaluate Response to Adalimumab in Rheumatoid Arthritis Patients ... adalimumab, a tumor necrosis ...

  7. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    Intolerance, loss response or failure to respond to treatment with at least one TNF-inhibitor within the previous 5 years; Washout of anti-TNF therapy for at ...

  8. Infliximab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Infliximab injection is used alone or together with other medicines (eg, methotrexate) to reduce the symptoms and prevent the progression of ...

  9. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

    The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...

  10. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

    ... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type ...